News & Videos - PENUMBRA INC.

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Penumbra, Inc. (NYSE: PEN) PR Newswire NEW YORK, April 8, 2025 NEW YORK , April 8, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Penumbra, Inc. (NYSE: PEN) on behalf of the company's shareholders. The investigation seeks to determine whether Penumbra's directors breached their fiduciary duties in connection with recent corporate actions. If you are a shareholder of Penumbra and are...

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 PR Newswire ALAMEDA, Calif., April 3, 2025 ALAMEDA, Calif. , April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time . A press release with first quarter 2025 financial results will be issued after market close that...

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors PR Newswire ALAMEDA, Calif., Feb. 21, 2025 ALAMEDA, Calif. , Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassing has notified the company that he will retire from the board of directors effective April 1, 2025 . Kassing joined Penumbra's Board of Directors in 2008 and has served as Presiding Director...

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire ALAMEDA, Calif., Feb. 18, 2025 ALAMEDA, Calif. , Feb. 18, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2024 . Financial Highlights: Adjusted revenue 1 of $321.3 million , excluding the $5.8 million impact of the Italian government's payback provision pertaining to prior years,...

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025 PR Newswire ALAMEDA, Calif., Jan. 21, 2025 ALAMEDA, Calif. , Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18, 2025 at 4:30 PM Eastern Time . A press release with fourth quarter and full year 2024 financial...

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire ALAMEDA, Calif., Dec. 30, 2024 ALAMEDA, Calif. , Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 . Event: 43 rd Annual J.P. Morgan Healthcare Conference Date: Monday, January 13, 2025 Time: 6:00pm ET / 3:00pm PT A webcast of the presentation can be...

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire ALAMEDA, Calif., Nov. 20, 2024 ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36 th Annual Healthcare Conference on Wednesday, December 4, 2024 . Event: Piper Sandler 36 th Annual Healthcare Conference Date: Wednesday, December 4, 2024 Time: 8:00am ET / 5:00am PT A webcast of the presentation...

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options PR Newswire ALAMEDA, Calif., Nov. 5, 2024 Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum thrombectomy to patients and the...

Penumbra, Inc. Reports Third Quarter 2024 Financial Results PR Newswire ALAMEDA, Calif., Oct. 30, 2024 ALAMEDA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024 . Revenue of $301.0 million in the third quarter of 2024, an increase of 11.1% or 10.9% in constant currency 1 , compared to the third quarter of 2023. U.S. thrombectomy revenue of $162.1 million in...

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke PR Newswire ALAMEDA, Calif., Oct. 14, 2024 ALAMEDA, Calif. , Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc . (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients with acute ischemic stroke. THUNDER is evaluating the safety and efficacy of the company's latest computer assisted vacuum thrombectomy (CAVT™) technology,...

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 PR Newswire ALAMEDA, Calif., Oct. 2, 2024 ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024 at 4:30 PM Eastern Time . A press release with third quarter 2024 financial results will be issued after market close that...

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe PR Newswire ALAMEDA, Calif., Sept. 16, 2024 Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightning Flash™ 2.0 will be the most advanced thrombectomy system on the European market to address venous and...

Penumbra, Inc. to Present at the Baird Global Healthcare Conference PR Newswire ALAMEDA, Calif., Aug. 27, 2024 ALAMEDA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 10, 2024 . Event: Baird Global Healthcare Conference Date: Tuesday, September 10, 2024 Time: 9:05am ET / 6:05am PT A webcast of the presentation can be accessed on the "Events and...

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference PR Newswire ALAMEDA, Calif., Aug. 21, 2024 ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 . Event: Wells Fargo Healthcare Conference Date: Wednesday, September 4, 2024 Time: 2:15pm ET/11:15am PT A webcast of the presentation can be accessed on the "Events and...

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization PR Newswire ALAMEDA, Calif., Aug. 13, 2024 To Include $100 Million Accelerated Share Repurchase ALAMEDA, Calif. , Aug. 13, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a share repurchase authorization in the amount of up to $200 million , allowing Penumbra to repurchase its common stock from time to time at such...

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference PR Newswire ALAMEDA, Calif., Aug. 2, 2024 ALAMEDA, Calif. , Aug. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024 . Event: Canaccord Genuity Growth Conference Date: Tuesday, August 13, 2024 Time: 9:00am ET/ 6:00am PT A webcast of the presentation can be accessed on the "Events and...

Penumbra, Inc. Reports Second Quarter 2024 Financial Results PR Newswire ALAMEDA, Calif., July 30, 2024 ALAMEDA, Calif. , July 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended June 30, 2024 . Revenue of $299.4 million in the second quarter of 2024, an increase of 14.5% or 14.7% in constant currency 1 , compared to the second quarter of 2023. U.S. thrombectomy revenue of...

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif., July 2, 2024 ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after market close on Tuesday, July 30, 2024 at 4:30 PM Eastern Time . A press release with second quarter 2024 financial results will be issued after market close that day....

'Outnumbered' panelists weigh in after former Atlanta City Attorney Shelitha Robertson was sentenced to seven years in prison for ......

Penumbra, Inc. to Present at the Truist Securities MedTech Conference PR Newswire ALAMEDA, Calif., June 4, 2024 ALAMEDA, Calif. , June 4, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 . Event: Truist Securities MedTech Conference Date: Tuesday, June 18, 2024 Time: 10:05am ET/7:05am PT A webcast of the presentation can be accessed on the "Events and...